secwatch.observer — SEC 8-K summary
======================================

Issuer:     Harmony Biosciences Holdings, Inc. (HRMY)
CIK:        0001802665
Form:       8-K
Filed at:   2023-01-06T23:59:59+00:00
Accession:  0001104659-23-001895
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CEO John Jacobs resigns; CMO Jeffrey Dayno named Interim CEO; Jeff Aronin becomes Executive Chairman
--------------------------------------------------------------------------------

- CEO John C. Jacobs resigns effective Jan 20, 2023 to pursue another opportunity; no disagreement with Company.
- Jeffrey M. Dayno, current CMO, appointed Interim CEO effective Jan 6, 2023; will remain CMO.
- Founder and Board Chairman Jeffrey S. Aronin appointed Executive Chairman to provide oversight during transition.
- Board expresses confidence in underlying business and strategic execution.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1802665/000110465923001895/0001104659-23-001895-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1802665/000110465923001895/tm232529d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-001895

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer